Cerity Partners
YDES

Cerity Partners’s YD Bio Ltd YDES Stock Holding History

Cerity Partners’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Hold
32,406
– – ﹤0.01% 2739
2025
Q4 		$395K Hold
32,406
– – ﹤0.01% 2246
2025
Q3 		$631K Buy
+32,406
New +$563K ﹤0.01% 1839

Other funds holding YDES

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cerity Partners's YDES Position: Q1 2026 in Review

Cerity Partners held its YD Bio Ltd (YDES) position steady in Q1 2026 at 32,406 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Cerity Partners first reported a position in YDES in Q3 2025 and has held it in 3 quarters since. The position peaked at $631K in Q3 2025. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

  • Cerity Partners held 32,406 shares of YD Bio Ltd worth $250K as of Q1 2026.
  • Cerity Partners left its YD Bio Ltd share count unchanged in Q1 2026.
  • YD Bio Ltd made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2739 holding.
  • Cerity Partners first reported a position in YD Bio Ltd in Q3 2025 and has held it in 3 quarters since.
  • Cerity Partners's YD Bio Ltd position peaked at $631K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.